NICOLE HORN: Open Payments
NPI 1518930700 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$880 in 46 payments from 10 companies in 2025. Trend: 2023 $199 · 2024 $1,035 · 2025 $880
Food & beverage: $880
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $171 |
| Novo Nordisk Inc | 7 | $142 |
| AstraZeneca Pharmaceuticals LP | 6 | $135 |
| PFIZER INC. | 6 | $130 |
| Lilly USA, LLC | 5 | $92 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Exact Sciences Corporation | 2 | $35 |
| Amgen Inc. | 2 | $32 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: VRAYLAR, NURTEC ODT, Ozempic, MOUNJARO, XIFAXAN, FARXIGA, CAPLYTA, AIRSUPRA.
Industry payments across VA — which companies pay providers there.
